Prostate Cancer New Treatment
More than 2 million men in the United States are living with prostate cancer, a cancer that forms within the tissues of the gland located between the bladder and rectum. This most common cancer in american men is treatable, especially when diagnosed early. Advanced medical techniques to treat and cure this cancer are continually being developed to control this debilitating disease. This article discusses prostrate cancer new treatments.
Over 180,000 men in the United States are diagnosed with prostate cancer each year. This disease is often diagnosed in men over the age of 50 and has a higher incidence rate among African Americans. Studies have proven that genetics are often associated with a higher risk for cancer, as the risk increases when close relatives have had the disease. There is also evidence that dietary factors increase or decrease the risk of prostate cancer. Symptoms of the disease include urinary problems, frequent lower-body pain, erectile dysfunction, as well as blood present in the urine. Most symptoms associated with prostate cancer occur during in the advanced stage of the disease, meaning, many men are unaware they actually have the disease until it is diagnosed in a routine prostate examination and a prostate-specific antigen (PSA) blood test, which is usually required between the ages of 40-50, depending on specific factors.
New prostate treatments are continually being researched and developed. Many of the prostate cancer new treatment methods are actually improvements to standard prostrate cancer treatments. New treatments involving surgery involve some doctors now utilizing sural nerve grafts to restore potency when nerves must be removed. This involves replacing the original nerves with nerves removed from the foot. This technique is still in its experimental stages.
For early stage prostate cancer, a high-intensity focused ultrasound (HIFU) destroys cancer cells with ultrasonic beams, and studies are presently being conducted to determine its effectiveness, as well as safety.
Dietary alternatives are also available as treatment. Studies have shown that men with a rising PSA after surgery or radiation had success with drinking pomegranate juice to lessen the rising PSA levels. Flaxseed supplements were also found to slow the cancer cell multiplication rate in a recent study. PSA levels also decreased in men who chose no treatment for localized prostate cancer, with a vegan diet and frequent exercise, which included yoga, according to a recent study.
A new drug called Abiraterone, with few side effects, may shrink tumors and lower PSA levels in men who no longer respond to hormone treatment and is presently under clinical tiral. A new chemotherapy drug called Satraplatin, a pill, is under study for use in men with advanced prostate cancer. A recent study concluded that a form of Vitamin D called Calcitriol shows tremendous results when it is combined with a Docetaxel chemotherapy drug called Taxotere and may contribute to prostate cancer patients living longer.
Immune system booster vaccines are currently under clinical trial testing and are used to treat, and not prevent, prostate cancer. Advantages of these vaccines are its limited side effects. Monoclonal antibiotics, immune system proteins designed to treat prostate cancer, are currently under trial, as well. An FDA-approved drug, Bevacizumab, is being tested with hormone therapy and chemotherapy for men with advanced stages of the disease.
To conclude, several promising prostate cancer new treatments are being tested and developed. Due to the treatments being considered improvements to existing available treatments, they may be available to prostate cancer patients in the near future.
Prostate Cancer: Treatment Options for Prostate Cancer
Often a combination of several drugs may be given to make this treatment more effective. Chemotherapy is usually used in men with advanced prostate cancer who are no longer responding [...]
Prostate Cancer: Prostate Cancer Treatment
The cancer was detected in the right side of the prostate in two samples out of twelve. The Gleason score was 8, which is considered to be in the aggressive range.
Prostate Cancer: Advanced Prostate Cancer
High-risk prostate cancer is aggressive, meaning it is likely to spread quickly outside the prostate. Understanding the risk level of your cancer will help your doctor decide [...]
Mail this post
Leave a Comment